Table 2.

Clinical features and genetic variants of patients with CD70 deficiency

Age at onset, y*Age at diagnosis, y*SexEthnicityConsanguinityMutation NM_001242.5Bacterial infectionsEBV-related symptomsMax EBV loadMalignancyOther symptomsTreatmentOutcomeCenterRef.
P34 Egyptian c.C535T, p.R179* No LPD NA ns-HL Recurrent fever HSCT Alive Paris 24  
P35 Iranian c.250delT, p.S84Pfs27* LRTI IM 6 910 ns-HL Behcet-like disease No Alive Tehran 26  
P36 36 Iranian c.250delT, p.S84Pfs27* Sinusitis Encephalitis 322 No No No Alive Tehran 26  
P37 16 Turkish c.555_557del, p.F186del* Otitis, diarrhea Cervical LAP 5 620 mc-HL Recurrent fever, chronic diarrhea HSCT Alive Ankara 26  
P38 Turkish c.555_557del, p.F186del* URTI Cervical LAP NA mc-HL No HSCT Alive Ankara 26  
P39 Caucasian c.163-2A>G, p.W55Dfs*44 No IM, LPD 27 700 No PFAPA-like periodic fever HSCT Alive Genova 27  
P40 16 Turkish c.G570A, p.Trp190* URTI LPD 17 856 HL PFAPA-like periodic fever HSCT Alive Ankara  
P41 11 Turkish c.C332T, p.T111M No Lymphadenitis 411 000 B-NHL No HSCT Died Istanbul  
P42 Turkish c.T2C, p.M1T LRTI IM LPD NA No No IgRT Alive Berlin 28  
P43 Turkish c.C332T, p.T111M LRTI LPD 233 No Chronic diarrhea HSCT Alive Istanbul  
P44 Turkish c.C332T, p.T111M LRTI No 309 402 ns-HL Chronic diarrhea HSCT Alive Istanbul  
P45 Turkish c.C332T, p.T111M LRTI No 24 000 ns-HL No Planned for HSCT Alive Istanbul  
P46 10 Iranian c.G437T, p.S146I LRTI, URTI IM, LPD 4 310 No Recurrent fever No Alive Tehran  
P47 Turkish c.C332T, p.T111M URTI LPD 67 500 No No RTX, sirolimus, planned for HSCT Alive Ankara  
P48 NA 14 Turkish c.C332T, p.T111M No No No No Planned for HSCT Alive Ankara  
P49 13 Turkish c.C332T, p.T111M No No Burkitt lymphoma No Planned for HSCT Alive Ankara  
Age at onset, y*Age at diagnosis, y*SexEthnicityConsanguinityMutation NM_001242.5Bacterial infectionsEBV-related symptomsMax EBV loadMalignancyOther symptomsTreatmentOutcomeCenterRef.
P34 Egyptian c.C535T, p.R179* No LPD NA ns-HL Recurrent fever HSCT Alive Paris 24  
P35 Iranian c.250delT, p.S84Pfs27* LRTI IM 6 910 ns-HL Behcet-like disease No Alive Tehran 26  
P36 36 Iranian c.250delT, p.S84Pfs27* Sinusitis Encephalitis 322 No No No Alive Tehran 26  
P37 16 Turkish c.555_557del, p.F186del* Otitis, diarrhea Cervical LAP 5 620 mc-HL Recurrent fever, chronic diarrhea HSCT Alive Ankara 26  
P38 Turkish c.555_557del, p.F186del* URTI Cervical LAP NA mc-HL No HSCT Alive Ankara 26  
P39 Caucasian c.163-2A>G, p.W55Dfs*44 No IM, LPD 27 700 No PFAPA-like periodic fever HSCT Alive Genova 27  
P40 16 Turkish c.G570A, p.Trp190* URTI LPD 17 856 HL PFAPA-like periodic fever HSCT Alive Ankara  
P41 11 Turkish c.C332T, p.T111M No Lymphadenitis 411 000 B-NHL No HSCT Died Istanbul  
P42 Turkish c.T2C, p.M1T LRTI IM LPD NA No No IgRT Alive Berlin 28  
P43 Turkish c.C332T, p.T111M LRTI LPD 233 No Chronic diarrhea HSCT Alive Istanbul  
P44 Turkish c.C332T, p.T111M LRTI No 309 402 ns-HL Chronic diarrhea HSCT Alive Istanbul  
P45 Turkish c.C332T, p.T111M LRTI No 24 000 ns-HL No Planned for HSCT Alive Istanbul  
P46 10 Iranian c.G437T, p.S146I LRTI, URTI IM, LPD 4 310 No Recurrent fever No Alive Tehran  
P47 Turkish c.C332T, p.T111M URTI LPD 67 500 No No RTX, sirolimus, planned for HSCT Alive Ankara  
P48 NA 14 Turkish c.C332T, p.T111M No No No No Planned for HSCT Alive Ankara  
P49 13 Turkish c.C332T, p.T111M No No Burkitt lymphoma No Planned for HSCT Alive Ankara  

LAP, lymphadenopathy; PFAPA, periodic fever, aphthous stomatitis, pharyngitis, cervical adenitis. See Table 1 for expansion of other abbreviations.

*

Age in years unless stated otherwise. Please note that the asterisks used in the “Age” column headings have no relation to those used in the “Mutation” column.

or Create an Account

Close Modal
Close Modal